deltatrials
Completed PHASE3 NCT01737697

Safety & Efficacy of Zirconium Silicate in Mild to Moderate Hyperkalemia

Multicenter, Two-phase, Multi-dose, Prospective, Randomized, Double-blind, Placebo-Controlled Study of Safety and Efficacy of Microporous, Fractionated, Protonated Zirconium Silicate in Mild to Moderate Hyperkalemia

Sponsor: ZS Pharma, Inc.

Conditions Hyperkalemia
Interventions Placebo ( subacute phase) Placebo (acute phase) Zirconium silicate (acute phase) Zirconium silicate (subacute phase)
Updated 8 times since 2017 Last updated: Sep 14, 2018 Started: Nov 30, 2012 Primary completion: Oct 31, 2013 Completion: Nov 30, 2013

A PHASE3 clinical study on Hyperkalemia, this trial is completed. The trial is conducted by ZS Pharma, Inc. and has accumulated 8 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Change History

8 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE3

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  4. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE3

  5. Nov 2018 — Jan 2021 [monthly]

    Completed PHASE3

▶ Show 3 earlier versions

  1. Jun 2018 — Nov 2018 [monthly]

    Completed PHASE3

  2. Feb 2017 — Jun 2018 [monthly]

    Completed PHASE3

  3. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE3

    First recorded

Nov 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • ZS Pharma, Inc.
Data source: ZS Pharma, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Anniston, United States, Atlantis, United States, Bethesda, United States, Biloxi, United States, Binghamton, United States, Brandon, United States, Brooklyn, United States, Brooksville, United States, Chula Vista, United States, Colorado Springs, United States and 32 more location s